MedImmune Ventures, Inc., 10% Owner at G1 Therapeutics, Inc. (GTHX), sold 267,812 shares at $19.75 ($5.3M) on 2017-12-01, disclosed to the SEC on 2017-12-05.
Open-market sale of $5.3M GTHX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.75 | 133,906 | $2.6M | 50.0% |
| 2 | $19.75 | 133,906 | $2.6M | 50.0% |
| Total | $19.75 avg | 267,812 | $5.3M | 100% |
| Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| GTHX | BUY | 2017-05-24 | $1.1M | — | Filing → |
| CATB | BUY | 2015-06-30 | $2.7M | — | Filing → |